Perceptive Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-26,667
| Closed | -$1.26M | – | 130 |
|
|
2018
Q1 | $1.26M | Hold |
26,667
| – | – | 0.04% | 99 |
|
|
2017
Q4 | $1.57M | Hold |
26,667
| – | – | 0.05% | 93 |
|
|
2017
Q3 | $1.65M | Hold |
26,667
| – | – | 0.06% | 94 |
|
|
2017
Q2 | $1.66M | Buy |
+26,667
| New | +$1.66M | 0.08% | 81 |
|
|
2017
Q1 | – | Sell |
-26,667
| Closed | -$1.02M | – | 162 |
|
|
2016
Q4 | $1.02M | Buy |
+26,667
| New | +$1.02M | 0.07% | 94 |
|
|
2016
Q3 | – | Sell |
-26,667
| Closed | -$964K | – | 192 |
|
|
2016
Q2 | $964K | Hold |
26,667
| – | – | 0.07% | 90 |
|
|
2016
Q1 | $1.07M | Buy |
+26,667
| New | +$1.07M | 0.09% | 95 |
|
|
2015
Q4 | – | Sell |
-26,667
| Closed | -$916K | – | 153 |
|
|
2015
Q3 | $916K | Hold |
26,667
| – | – | 0.07% | 84 |
|
|
2015
Q2 | $1.44M | Hold |
26,667
| – | – | 0.09% | 98 |
|
|
2015
Q1 | $1.78M | Buy |
+26,667
| New | +$1.78M | 0.14% | 78 |
|